Formulation is the discipline the supplement industry most often skips. It is easy to put an impressive ingredient on a label; it is harder to put it in at the dose that was studied, in a form that stays stable to the end of shelf life, in a format a dog, horse or hen will actually consume, alongside other actives that don't interfere with it. That harder version is what Natural Science Group's formulation practice does, for our own brands and for partners.
Starting from the evidence, not the trend
Our formulation library holds two dozen actives, each admitted on the same test: published, peer-reviewed research relevant to the species and outcome we want to support. Collagen peptides for joint support, omega-3 fatty acids, pre- and probiotics for digestive balance, botanicals with studied calming effects, targeted micronutrients — the library spans categories, but the admission standard doesn't move.
Two consequences follow. First, dose honesty: if the research showing an effect used a certain intake, our formulation targets a comparable, species-appropriate level — not a "fairy dust" inclusion that borrows the ingredient's reputation at a fraction of the studied dose. Second, claim discipline: the words on the label are set by what the evidence and the regulatory category support, not by what marketing would prefer. Our human-nutrition heritage taught us that both disciplines eventually become commercial advantages, because vets, retailers and regulators all ask the same question sooner or later: where's the data?
Formulating for a species, not just a molecule
An active that works in one species cannot be assumed to work identically in another — digestive systems, metabolic rates and body masses differ too much. Species translation is the core of animal formulation:
- Dose scaling that respects physiology rather than naive body-weight arithmetic.
- Matrix design around the species' diet — what a supplement is mixed into changes how it should be built.
- Palatability engineering — the best formulation in the world does nothing in a refused bowl. Flavour systems, texture and format are developed per species and tested before launch.
- Format selection — soft chews, gels, powders, liquids, pellets and feed-grade premixes, chosen for the animal, the owner or keeper who doses it, and the setting it is dosed in. A yard, a parlour and a kitchen counter are three different worlds.
Stability, compatibility, manufacturability
A formulation is not finished when the actives are chosen. Bench-to-batch development means proving the recipe survives reality: actives that remain within specification through shelf life; ingredients that coexist without degrading one another; a recipe that behaves the same in a production batch as it did at the bench. We formulate with manufacture in the room from day one — it is the same company, often the same conversation — so products are designed to be made well, not just designed.
From brief to bench to batch
A typical development engagement runs:
- The brief — species, outcome to support, format, commercial constraints, regulatory category.
- Evidence review — what the literature supports, at what doses, and where the evidence is genuinely thin. That review shapes both formulation and permissible claims.
- Candidate formulation — recipe development, palatability and stability work, iteration.
- Validation — analytical confirmation that the product contains what it should; where the claim warrants it, a clinical trial.
- Scale-up — transfer to production with specifications, batch documentation and ongoing quality control.
The same process serves a companion chew, an equine powder and a livestock premix; only the physiology and the regulatory frame change. That range — companion, equine, agricultural and exotic — is deliberate: formulating across species keeps the science honest, because habits that go unquestioned in one market get exposed in another.
Frequently asked questions
What does "formulated from peer-reviewed actives" actually mean?
Every active in our library was selected because published, peer-reviewed research supports its role for a relevant species and outcome — and our formulations target doses comparable to what was studied, not token inclusions of a fashionable ingredient.
Can NSG formulate a product to a partner's brief?
Yes. Formulation-to-brief is the heart of our white-label and co-development programmes: a partner brings the brand, audience and commercial constraints; we bring the evidence review, recipe development, testing and UK manufacture.
Which formats can NSG develop?
Soft chews, gels, powders, liquids, pellets and feed-grade premixes. Format is chosen per species and setting, and palatability is developed and tested as part of the formulation, not assumed.
How does NSG decide the dose of an active?
From the published research, translated to the target species with appropriate scaling — and where evidence for a species is thin, we formulate conservatively and keep the label's claims within what can be supported.
Does NSG formulate for all animal species?
Our practice spans companion animals, horses, production livestock and — case by case — exotic species for zoos, sanctuaries and specialist keepers. If we don't believe the evidence supports a product for your species and goal, we'll say so.